al amyloidosis

The latest news about al amyloidosis: headlines, AI summaries and the full story from every source.

• Immix Biopharma Reports 95% Complete Response Rate in Relapsed/Refractory AL Amyloidosis Trial GlobeNewsWire · May 21, 2026, 10:00 UTC
• Immix Biopharma Completes Enrollment for Key Phase 2 Trial Yahoo Finance · May 5, 2026, 17:05 UTC